Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–19. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Cao M, Ding C, Xia C, et al. Attributable deaths of liver cancer in China. Chin J Cancer Res. 2021;33(4):480–489. doi: 10.21147/j.issn.1000-9604.2021.04.05
   PubMed Web of Science ®Google Scholar
• Yu Z, Zhang Y, Shao S, et al. Identification of CDCA2 as a diagnostic and prognostic marker for hepatocellular carcinoma. Front Oncol. 2021;11:755814. doi: 10.3389/fonc.2021.755814
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604. doi: 10.1038/s41575-019-0186-y
   PubMed Web of Science ®Google Scholar
• Gallage S, Garcia-Beccaria M, Szydlowska M, et al. The therapeutic landscape of hepatocellular carcinoma. Med. 2021;2(5):505–552. doi: 10.1016/j.medj.2021.03.002
   PubMedGoogle Scholar
• Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China. Cancer Lett. 2018;412:283–288. doi: 10.1016/j.canlet.2017.10.008
   PubMed Web of Science ®Google Scholar
• Prospective suRveillance for very early hepatoCellular c Aep: [expert consensus on early screening strategies for liver cancer in China]. Zhonghua Gan Zang Bing Za Zhi. 2021;29(6):515–522. doi: 10.3760/cma.j.cn501113-20210605-00264
   PubMedGoogle Scholar
• Liu XN, Cui DN, Li YF, et al. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. World J Gastroenterol. 2019;25(30):4199–4212. doi: 10.3748/wjg.v25.i30.4199
   PubMed Web of Science ®Google Scholar
• Tzartzeva K, Obi J, Rich NE, et al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology. 2018;154(6):1706–1718 e1701. doi: 10.1053/j.gastro.2018.01.064
   PubMed Web of Science ®Google Scholar
• Xie DY, Ren ZG, Zhou J, et al. Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2019;9(4):452–463. doi: 10.21037/hbsn-20-480
   Web of Science ®Google Scholar
• Professional committee for P, control of H, pancreatic diseases of Chinese preventive medicine A, professional committee for hepatology CRHA, Chinese society of hepatology CMA, prevention of infection related cancer group SCoCP, control of Chinese preventive medicine A: [guideline for stratified screening and surveillance of primary liver cancer(2020 edition)]. Zhonghua Gan Zang Bing Za Zhi. 2021;29(1):25–40. doi: 10.3760/cma.j.cn112152-20201109-00970
   PubMedGoogle Scholar
• Tzartzeva K, Singal AG. Testing for AFP in combination with ultrasound improves early liver cancer detection. Expert Rev Gastroenterol Hepatol. 2018;12(10):947–949. doi: 10.1080/17474124.2018.1512855
   PubMed Web of Science ®Google Scholar
• Simmons O, Fetzer DT, Yokoo T, et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis. Aliment Pharmacol Ther. 2017;45(1):169–177. doi: 10.1111/apt.13841
   PubMed Web of Science ®Google Scholar
• Singal AG, Hoshida Y, Pinato DJ, et al. International liver cancer association (ILCA) white paper on biomarker development for hepatocellular carcinoma. Gastroenterology. 2021;160(7):2572–2584. doi: 10.1053/j.gastro.2021.01.233
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11):1148–1159. doi: 10.1056/NEJMra072067
   PubMed Web of Science ®Google Scholar
• Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016;8(9):8. doi: 10.1101/cshperspect.a019505
   Web of Science ®Google Scholar
• Irizarry RA, Ladd-Acosta C, Wen B, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41(2):178–186. doi: 10.1038/ng.298
   PubMed Web of Science ®Google Scholar
• Baylin SB, Jones PA. A decade of exploring the cancer epigenome — biological and translational implications. Nat Rev Cancer. 2011;11(10):726–734. doi: 10.1038/nrc3130
   PubMed Web of Science ®Google Scholar
• Luo B, Ma F, Liu H, et al. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. BMC Med. 2022;20(1):8. doi: 10.1186/s12916-021-02201-3
   PubMed Web of Science ®Google Scholar
• Li J, Xu M, Peng J, et al. Novel technologies in cfDNA analysis and potential utility in clinic. Chin J Cancer Res. 2021;33(6):708–718. doi: 10.21147/j.issn.1000-9604.2021.06.07
   PubMed Web of Science ®Google Scholar
• Lin C, Liu X, Zheng B, et al. Liquid Biopsy, ctDNA Diagnosis through NGS. Life (Basel). 2021;11(9):11. doi: 10.3390/life11090890
   Web of Science ®Google Scholar
• Xu RH, Wei W, Krawczyk M, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat Mater. 2017;16(11):1155–1161. doi: 10.1038/nmat4997
   PubMed Web of Science ®Google Scholar
• Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra224. doi: 10.1126/scitranslmed.3007094
   Web of Science ®Google Scholar
• Newman AM, Bratman SV, To J, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med. 2014;20(5):548–554. doi: 10.1038/nm.3519
   PubMed Web of Science ®Google Scholar
• Board RE, Knight L, Greystoke A, et al. DNA methylation in circulating tumour DNA as a biomarker for cancer. Biomark Insights. 2008;2:307–319. doi: 10.1177/117727190700200003
   PubMedGoogle Scholar
• Kisiel JB, Dukek BA, VSRK R, et al. Hepatocellular carcinoma detection by plasma methylated DNA: discovery, phase I Pilot, and phase II clinical validation. Hepatology. 2019;69(3):1180–1192. doi: 10.1002/hep.30244
   PubMed Web of Science ®Google Scholar
• Luo H, Wei W, Ye Z, et al. Liquid biopsy of methylation biomarkers in cell-free DNA. Trends Mol Med. 2021;27(5):482–500. doi: 10.1016/j.molmed.2020.12.011
   PubMed Web of Science ®Google Scholar
• Li JJ, Lv Y, Ji H. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis. PeerJ. 2022;10:e14303. doi: 10.7717/peerj.14303
   PubMed Web of Science ®Google Scholar
• Pezzuto F, Buonaguro L, Buonaguro FM, et al. The role of circulating free DNA and MicroRNA in non-invasive diagnosis of HBV- and HCV-Related hepatocellular carcinoma. Int J Mol Sci. 2018;19(4):19. doi: 10.3390/ijms19041007
   Web of Science ®Google Scholar
• Zhang L, Dong L, Lu C, et al. Methylation of SDC2/TFPI2 and its diagnostic value in colorectal tumorous lesions. Front Mol Biosci. 2021;8:706754. doi: 10.3389/fmolb.2021.706754
   PubMed Web of Science ®Google Scholar
• Moss J, Magenheim J, Neiman D, et al. Dor Y: comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat Commun. 2018;9(1):5068. doi: 10.1038/s41467-018-07466-6
   PubMed Web of Science ®Google Scholar
• Palazzo U, Rapisarda E, Torrisi L. Structural modifications induced by ionic implantation on functional surfaces of prosthetic attachments. Stomatol Mediterr. 1988;8(4):387–394.
   PubMedGoogle Scholar
• Mei Q, Yu M, Chen Q. Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm). World J Clin Cases. 2022;10(24):8525–8534. doi: 10.12998/wjcc.v10.i24.8525
   PubMed Web of Science ®Google Scholar
• Lewin J, Kottwitz D, Aoyama J, et al. Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study. BMC Gastroenterol. 2021;21(1):136. doi: 10.1186/s12876-021-01714-8
   PubMed Web of Science ®Google Scholar
• Li H, Jing C, Wu J, et al. Circulating tumor DNA detection: A potential tool for colorectal cancer management. Oncol Lett. 2018;17:1409–1416. doi: 10.3892/ol.2018.9794
   PubMed Web of Science ®Google Scholar
• Chalasani NP, Ramasubramanian TS, Bhattacharya A, et al. A novel blood-based panel of methylated DNA and protein markers for detection of early-stage hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2021;19(12):2597–2605 e2594. doi: 10.1016/j.cgh.2020.08.065
   PubMed Web of Science ®Google Scholar
• Chalasani NP, Porter K, Bhattacharya A, et al. Validation of a novel multitarget blood test shows high sensitivity to detect early stage hepatocellular carcinoma. Clinical Gastroenterology And Hepatology. 2022;20(1):173–182 e177. doi: 10.1016/j.cgh.2021.08.010
   PubMed Web of Science ®Google Scholar
• Wang B, Li D, Rodriguez-Juarez R, et al. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells. BMC Cancer. 2018;18(1):817. doi: 10.1186/s12885-018-4711-0
   PubMedGoogle Scholar
• Liu D, Ma X, Yang F, et al. Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer. Cancer Gene Ther. 2020;27(6):473–485. doi: 10.1038/s41417-019-0125-7
   PubMed Web of Science ®Google Scholar
• Yao Y, Gong G, Guo Z, et al. A pan-cancer analysis of ring finger protein 135 and its relationship to triple-negative breast cancer proliferation and metastasis. Aging. 2022;14:9758–9772. doi: 10.18632/aging.204429
   PubMedGoogle Scholar
• Wang X, Chen M, Liang X, et al. RNF135 promoter methylation is associated with immune infiltration and prognosis in hepatocellular carcinoma. Front Oncol. 2021;11:752511. doi: 10.3389/fonc.2021.752511
   PubMed Web of Science ®Google Scholar
• Liang W, Xu Z, Kong F, et al. Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma. Front Genet. 2022;13:1065693. doi: 10.3389/fgene.2022.1065693
   PubMed Web of Science ®Google Scholar
• Shen JY, Li C, Wen TF, et al. Nazar Highness T: liver transplantation versus surgical resection for HCC meeting the milan criteria: a propensity score analysis. Medicine (Baltimore). 2016;95(52):e5756. doi: 10.1097/MD.0000000000005756
   PubMed Web of Science ®Google Scholar
• Li W, Xiao H, Wu H, et al. Liver transplantation versus liver resection for stage I and II hepatocellular carcinoma: results of an instrumental variable analysis. Front Oncol. 2021;11:592835. doi: 10.3389/fonc.2021.592835
   PubMed Web of Science ®Google Scholar
• Lingiah VA, Niazi M, Olivo R, et al. Liver transplantation beyond milan criteria. J Clin Transl Hepatol. 2020;8(1):69–75. doi: 10.14218/JCTH.2019.00050
   PubMed Web of Science ®Google Scholar